Cooper Mr

598 total citations
27 papers, 494 citations indexed

About

Cooper Mr is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, Cooper Mr has authored 27 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Hematology and 5 papers in Genetics. Recurrent topics in Cooper Mr's work include Multiple Myeloma Research and Treatments (5 papers), Cancer Treatment and Pharmacology (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Cooper Mr is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Cancer Treatment and Pharmacology (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Cooper Mr collaborates with scholars based in United States. Cooper Mr's co-authors include Frederick Richards, Spurr Cl, Leon Stutzman, Glicksman As, A. Gottlieb, N I Nissen, Muss Hb, Capizzi Rl, Matthew Poole and Prichard Rw and has published in prestigious journals such as PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

In The Last Decade

Cooper Mr

27 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cooper Mr United States	10	230	161	160	115	97	27	494
A. Gottlieb United States	9	143 0.6×	231 1.4×	101 0.6×	109 0.9×	162 1.7×	11	451
C Jacquillat France	10	149 0.6×	168 1.0×	102 0.6×	120 1.0×	73 0.8×	62	444
A Ferrant Belgium	13	342 1.5×	175 1.1×	130 0.8×	110 1.0×	102 1.1×	27	624
Metter Ge United States	9	189 0.8×	261 1.6×	78 0.5×	93 0.8×	127 1.3×	13	538
R Battista Italy	14	278 1.2×	141 0.9×	282 1.8×	91 0.8×	142 1.5×	42	581
Jorge A. Spinolo United States	11	379 1.6×	436 2.7×	145 0.9×	150 1.3×	109 1.1×	18	794
Prentice Hg United Kingdom	14	354 1.5×	177 1.1×	117 0.7×	87 0.8×	23 0.2×	20	622
C Skosey United States	7	206 0.9×	241 1.5×	152 0.9×	209 1.8×	55 0.6×	7	623
B.M. Dale Australia	13	371 1.6×	304 1.9×	53 0.3×	105 0.9×	146 1.5×	28	716
D. Urbanitz Germany	8	458 2.0×	148 0.9×	291 1.8×	161 1.4×	56 0.6×	41	665

Countries citing papers authored by Cooper Mr

Since Specialization

Citations

This map shows the geographic impact of Cooper Mr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cooper Mr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cooper Mr more than expected).

Fields of papers citing papers by Cooper Mr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cooper Mr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cooper Mr. The network helps show where Cooper Mr may publish in the future.

Co-authorship network of co-authors of Cooper Mr

This figure shows the co-authorship network connecting the top 25 collaborators of Cooper Mr. A scholar is included among the top collaborators of Cooper Mr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cooper Mr. Cooper Mr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mr, Cooper, et al.. (1995). Community Clinical Oncology Program as a recruitment vehicle for cancer control research. The Southeast Cancer Control Consortium experience.. PubMed. 56(6). 283–6. 3 indexed citations

Mr, Cooper, et al.. (1995). Phase I study of continuous infusion 6-thioguanine in patients with acute leukemia.. PubMed. 9(5). 770–3. 5 indexed citations

Dc, Tormey, et al.. (1992). Chemotherapy versus observation in high-risk node-negative breast cancer patients.. PubMed. 97–104. 5 indexed citations

Mr, Cooper. (1991). A review of the clinical studies of alpha-interferon in the management of multiple myeloma.. PubMed. 18(5 Suppl 7). 18–29. 18 indexed citations

Mr, Cooper. (1988). Interferons in the management of multiple myeloma.. PubMed. 15(5 Suppl 5). 21–5. 9 indexed citations

Rw, Prichard, et al.. (1987). Comparison of the usefulness of bone marrow sections and smears in diagnosis of multiple myeloma.. PubMed. 1(1). 35–43. 9 indexed citations

Mr, Cooper, A Fefer, Reiner Kempf, et al.. (1986). Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial.. PubMed. 70(4). 473–6. 33 indexed citations

Rl, Capizzi, et al.. (1985). Phase I trials of high-dose cytosine arabinoside (HDara-C) and HDara-C plus cisplatin in patients with advanced malignancies.. PubMed. 12(2 Suppl 3). 166–70. 6 indexed citations

Rl, Capizzi, Matthew Poole, Cooper Mr, et al.. (1984). Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase.. PubMed. 63(3). 694–700. 159 indexed citations

10.

As, Glicksman, et al.. (1982). Second malignant neoplasms in patients successfully treated for Hodgkin's disease: a Cancer and Leukemia Group B study.. PubMed. 66(4). 1035–44. 124 indexed citations

11.

Mr, Cooper. (1982). Warning: traditional employee attitude surveys don't work.. PubMed. 71(8). 56–7. 1 indexed citations

12.

Mr, Cooper, et al.. (1981). Intensive plasma exchange in thrombotic thrombocytopenic purpura (TTP).. PubMed. 42(6). 403–4. 1 indexed citations

13.

Mr, Cooper, et al.. (1979). Complications of cytotoxic antineoplastic chemotherapy.. PubMed. 40(2). 73–8. 1 indexed citations

14.

Haid, Max, et al.. (1977). Adriamycin-methotrexate combination chemotherapy of advanced carcinoma of the cervix.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 50(1). 103–5. 7 indexed citations

15.

Mr, Cooper, et al.. (1977). HLA associations with acute myelogenous leukemia.. PubMed. 16. 81–9. 2 indexed citations

16.

Hb, Muss, et al.. (1976). Adriamycin and CCNU in the treatment of advanced breast cancer.. PubMed. 60(11). 1687–9. 7 indexed citations

17.

Richards, Frederick, et al.. (1974). Study of methyl-CCNU(NSC-95441) in the treatment of lung cancer.. PubMed. 57(4). 419–22. 1 indexed citations

18.

Mr, Cooper, et al.. (1972). Stimulation of oxidative metabolism in polymorphonuclear leukocytes by catecholamines.. PubMed. 11(3). 263–76. 15 indexed citations

19.

Mr, Cooper, et al.. (1972). NAD kinase in human polymorphonuclear leukocytes.. PubMed. 12(4). 387–98. 2 indexed citations

20.

Mr, Cooper, et al.. (1971). Respiratory syncytial virus infection in children in West Bengal.. PubMed. 59(9). 1354–64. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact